Vulvar Aphthous Ulcers in an Adolescent After Coronavirus Disease 2019 (COVID-19) Vaccination.
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
received:
14
02
2022
accepted:
19
05
2022
pubmed:
6
8
2022
medline:
15
11
2022
entrez:
5
8
2022
Statut:
ppublish
Résumé
Nonsexually acquired genital ulcers have been described among girls who are prepubertal after various viral illnesses due to mucosal inflammation from an immunologic response. Until recently, nonsexually acquired genital ulcers have only been associated with viral infections. We present a case of an adolescent girl developing nonsexually acquired genital ulcers after both her first and second coronavirus disease 2019 (COVID-19) vaccine doses. Her course followed an expected timeline for severity and resolution of ulcers. Aphthous ulcers may arise from inflammatory effects of COVID-19 vaccination. Clinical monitoring after COVID-19 vaccination from all formulations should include assessment for nonsexually acquired genital ulcers if vaginal pain is reported.
Sections du résumé
BACKGROUND
Nonsexually acquired genital ulcers have been described among girls who are prepubertal after various viral illnesses due to mucosal inflammation from an immunologic response. Until recently, nonsexually acquired genital ulcers have only been associated with viral infections.
CASE
We present a case of an adolescent girl developing nonsexually acquired genital ulcers after both her first and second coronavirus disease 2019 (COVID-19) vaccine doses. Her course followed an expected timeline for severity and resolution of ulcers.
CONCLUSIONS
Aphthous ulcers may arise from inflammatory effects of COVID-19 vaccination. Clinical monitoring after COVID-19 vaccination from all formulations should include assessment for nonsexually acquired genital ulcers if vaginal pain is reported.
Identifiants
pubmed: 35930388
doi: 10.1097/AOG.0000000000004885
pii: 00006250-990000000-00549
pmc: PMC9377366
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
514-517Informations de copyright
Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Financial Disclosure The authors did not report any potential conflicts of interest.
Références
Huppert JS, Gerber MA, Deitch HR. Vulvar ulcers in young females: a manifestation of aphthosis. J Pediatr Adolesc Gynecol 2006;19:195–204. doi: 10.1016/j.jpag.2006.02.006
doi: 10.1016/j.jpag.2006.02.006
Farhi D, Wendling J, Molinari E. Non–sexually related acute genital ulcers in 13 pubertal girls: a clinical and microbiological study. Arch Dermatol 2009;145:38–45. doi: 10.1001/archdermatol.2008.519
doi: 10.1001/archdermatol.2008.519
Farag Ahmed ES. Nonsexually acquired acute genital ulceration: a commonly misdiagnosed condition. Gulf J Dermatol Venereol 2018;25:13
Dixit S, Bradford J, Fischer G. Management of nonsexually acquired genital ulceration using oral and topical corticosteroids followed by doxycycline prophylaxis. J Am Acad Dermatol 2013;68:797–802. doi: 10.1016/j.jaad.2012.10.014
doi: 10.1016/j.jaad.2012.10.014
Lehman J, Bruce A, Wetter D. Reactive nonsexually related acute genital ulcers: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol 2010;63:44–51. doi: 10.1016/j.jaad.2009.08.038
doi: 10.1016/j.jaad.2009.08.038
Falkenhain-López D, Agud-Dios M, Ortiz-Romero P. COVID-19-related acute genital ulcers. J Eur Acad Dermatol Venereol 2020;34:e655–6. doi: 10.1111/jdv.16740
doi: 10.1111/jdv.16740
Dominguez-Santas M, Diaz-Guimaraens B, Fernandez-Nieto D. Minor aphthae associated with SARS-CoV-2 infection. Int J Dermatol 2020;59:1022–3. doi: 10.1111/ijd.15004
doi: 10.1111/ijd.15004
Christl J, Alaniz VI, Appiah L, Buyers E, Scott S, Huguelet PS. Vulvar aphthous ulcer in an adolescent with COVID-19. J Pediatr Adolescgynecol 2021;34:418–20. doi: 10.1016/j.jpag.2021.02.098
doi: 10.1016/j.jpag.2021.02.098
Fi Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccin 2008;7:467–79. doi: 10.1586/14760584.7.4.467
doi: 10.1586/14760584.7.4.467
Markle JG, Fish EN. SeXX matters in immunity. Trends Immunology 2014;35:97–104. doi: 10.1016/j.it.2013.10.006
doi: 10.1016/j.it.2013.10.006
Bulur I, Onder M. Behçet disease: new aspects. Clin Dermatol 2017;35:421–34. doi: 10.1016/j.clindermatol.2017.06.004
doi: 10.1016/j.clindermatol.2017.06.004
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363–74. doi: 10.1038/s41577-020-0311-8
doi: 10.1038/s41577-020-0311-8
Drucker A, Corrao K, Gandy M. Vulvar aphthous ulcer following Pfizer-BioNTech COVID-19 vaccine–a case report. J Pediatr Adolesc Gynecol 2021;35:165–6. doi: 10.1016/j.jpag.2021.10.007
doi: 10.1016/j.jpag.2021.10.007
Wojcicki AV, O'Brien KLF. Vulvar aphthous ulcer in an adolescent after Pfizer-BioNTech (BNT162b2) COVID-19 vaccination. J Pediatr Adolesc Gynecol 2022;35:167–70. doi: 10.1016/j.jpag.2021.10.005
doi: 10.1016/j.jpag.2021.10.005
Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol 2020;20:615–32. doi: 10.1038/s41577-020-00434-6
doi: 10.1038/s41577-020-00434-6
Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, et al. COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol 2022;269:1093–106. doi: 10.1007/s00415-021-10780-7
doi: 10.1007/s00415-021-10780-7
Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J Ophthalmic Vis Res 2021;16:490–501. doi: 10.18502/jovr.v16i3.9443
doi: 10.18502/jovr.v16i3.9443
Fernandez‐Nieto D, Hammerle J, Fernandez‐Escribano M, Moreno‐del Real CM, Garcia‐Abellas P, Carretero‐Barrio I, et al. Skin manifestations of the BNT162b2 mRNA COVID‐19 vaccine in healthcare workers. ‘COVID‐arm’: a clinical and histological characterization. J Eur Acad Dermatol Venereol 2021;35:e425–7. doi: 10.1111/jdv.17250
doi: 10.1111/jdv.17250
Haynes BF, Fauci AS. The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest 1978;61:703–7. doi: 10.1172/JCI108982
doi: 10.1172/JCI108982
Golding B, Lee Y, Golding H, Khurana S. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report. Ann Rheum Dis 2021;80:1359–61. doi: 10.1136/annrheumdis-2021-220993
doi: 10.1136/annrheumdis-2021-220993
Nessib DB, Fazaa A, Miladi S, Sellami M, Ouenniche K, Souabni L, et al. Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature. Therapie 2021;76:215–9. doi: 10.1016/j.therap.2020.08.002
doi: 10.1016/j.therap.2020.08.002